Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abramson Cancer Center at Penn Medicine
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with biopsy-proven WHO Grade IV glioblastoma, after gross-total or near-total resection, who are undergoing definitive chemoradiation as part of their treatment regimen
Age 18 or older
Ability to give signed informed consent
Karnofsky Performance Status (KPS) at least 70
You may not be if
Placement of Gliadel wafers
Participation in another investigational trial
Active treatment of another malignancy
Clareo Health | Personalized Radiation Therapy for GBM
